Here are six quick facts:
1. Eight analysts rated the stock a “buy,” nine rated the stock an “outperform” and seven rated the stock a “hold.”
2. The 24 analysts gave an estimate of $1.46 per share for this quarter.
3. The analysts gave a high estimate of $1.68 and a low estimate of $0.98.
4. The company’s revenue is expected to hit $10.22 billion.
5. The analysts forecasted HCA would report earnings of $6.25 per share, for the full year.
6. HCA is expected to maintain an annual growth rate of 10.87 percent for the next five years.
More articles on transactions & valuation:
9 new outpatient surgery centers in February 2016
HCA to open provider-based ER in Las Vegas: 6 things to know
SCA Director sells 11k shares — 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
